The general survival period of patients with aplastic anemia ranges from 1 to 10 years, and the actual survival time is related to a number of factors, such as individual’s physical condition, progression of the disease, and sensitivity to treatment.
1. Non-severe aplastic anemia can be relieved or even cured by intermittent blood transfusion and the use of drugs to promote bone marrow hematopoiesis, such as testosterone propionate, etc., under the guidance of doctors, which may have no effect on life expectancy.
2. For patients with severe aplastic anemia, 80% of them can be relieved and prolong their life by strengthening immunotherapy (cyclosporine, anti-human thymocyte globulin) or hematopoietic stem cell transplantation.
Patients can reduce the adverse effects of the disease through “early detection, early diagnosis, early treatment”, many patients are likely to survive for a long time, it is recommended that patients establish confidence in treatment, maintain a positive and optimistic attitude, and timely and regular treatment. The key to how long a person can live with remittent anemia is whether he or she follows the doctor’s instructions to standardize treatment and whether he or she maintains a healthy lifestyle.